CCRM

Commercializing Living Therapies with CCRM

Science EN ↓ 28 episodi

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

Visita il sito del podcast e sostieni chi lo crea: www.ccrm.ca

Autore

CCRM

Categoria

Science

Sito del podcast

www.ccrm.ca

Ultimo episodio

15 ott 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android 10 mln+ di download · valutazione 4,7+ iOS in arrivo

Episodi

Moving from A to B 14.02.2022

Manufacturing and supply chain issues in cell and gene therapies.    Featuring:  Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting  Rob Jones, Vice President, Global Bioservices, Cryoport Systems   It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony...

Chaperoning innovation through the valley of death 14.01.2022

The business of regenerative medicine and investment.   Featuring:  Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises  Geoff MacKay, President and CEO, AVROBIO  Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Jo...

The importance of educating the public about cell and gene therapies 14.12.2021

How can the regenerative medicine community create broader societal awareness?  Featuring:  Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem...

Ascolta il podcast Commercializing Living Therapies with CCRM su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici